Day's Low
Day's High
52 Week's Low
52 Week's High
Returns % | |
1 Month Return | + 12.25 % |
3 Month Return | + 49.51 % |
1 Year Return | + 255.32 % |
Market Stats | |
Previous Close | ₹1,490.20 |
Open | ₹1,496.05 |
Volume | 1.96L |
Upper Circuit | - |
Lower Circuit | - |
Market Cap | ₹24,211.62Cr |
P/E Ratio | -75.22 |
PEG Ratio | -4.75 |
Market Cap | ₹24,211.62 Cr |
P/B Ratio | 5 |
EPS | -30.65 |
Dividend Yield | 0 |
Sector | Pharmaceuticals |
ROE | 0 |
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
---|---|---|---|---|---|---|
NA | ₹24,211.62 Cr | 109.14% | 0.77 | -₹472 Cr | ₹2,798 Cr | |
BUY | ₹28,426.00 Cr | 112.52% | 0.52 | ₹300 Cr | ₹1,051 Cr | |
BUY | ₹17,481.58 Cr | 28.58% | 0.57 | ₹72 Cr | ₹6,702 Cr | |
NA | ₹6,532.30 Cr | 5.83% | 0.79 | -₹388 Cr | ₹75 Cr | |
BUY | ₹15,623.72 Cr | 48.35% | 0.68 | ₹218 Cr | ₹1,296 Cr |
Organisation | Wockhardt Ltd |
Headquarters | Mumbai |
Industry | Pharmaceuticals |
E-voting on shares | Click here to vote |
Key events for Wockhardt Ltd
Wockhardt Shares Surge After Zaynich Success - 16 Dec, 2024
Wockhardt Launches India's First Indigenous Antibiotic - 06 Dec, 2024
Wockhardt Shares Surge to New 52-Week High - 28 Nov, 2024
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Best in 3 Years
In the last 3 years, WOCKPHARMA has outperformed top 5 stocks with highest market-cap in Pharmaceuticals
Price Rise
In the last 3 months, WOCKPHARMA stock has moved up by 49.5%
Revenue Rich
Revenue is up for the last 4 quarters, 709.0 Cr → 818.0 Cr (in ₹), with an average increase of 4.6% per quarter
MF Holding Up
Mutual Funds have increased holdings from 2.95% to 7.09% in Nov 2024 quarter
Best in 1 Year
In the last 1 year, WOCKPHARMA has outperformed top 5 stocks with highest market-cap in Pharmaceuticals
Retail Holding Down
Retail Investor have decreased holdings from 36.21% to 34.39% in Nov 2024 quarter
Promoter Holding Down
Promoters have decreased holdings from 51.99% to 49.09% in Nov 2024 quarter
Profit Down
Netprofit is down for the last 2 quarters, -14.0 Cr → -22.0 Cr (in ₹), with an average decrease of 57.1% per quarter
FII Holding Down
Foreign Institutions have decreased holdings from 6.69% to 6.61% in Nov 2024 quarter
Investors | Holdings % | FY Quarter | 3M change |
---|---|---|---|
Promoter Holdings | 49.09% | ||
Foreign Institutions | 6.61% | ||
Mutual Funds | 7.09% | 140.47 | |
Retail Investors | 34.39% | ||
Others | 2.82% | 30.14 |
Wockhardt Ltd in the last 5 years
Lowest (-94.57x)
October 8, 2021
Today (-75.22x)
December 24, 2024
Industry (56.56x)
December 24, 2024
Highest (12.70x)
May 26, 2021
Wockhardt Ltd’s net profit jumped 71.43% since last year same period to ₹-22Cr in the Q2 2024-2025. On a quarterly growth basis, Wockhardt Ltd has generated -57.14% fall in its net profits since last 3-months.
Read More about Earnings ResultsIn the quarter ending September 2016, Wockhardt Ltd has declared dividend of ₹10 - translating a dividend yield of 0.67%.
Read More about DividendsBearish
Neutral
Bullish
Wockhardt Ltd is currently in a Bullish trading position according to technical analysis indicators.
Wockhardt Ltd (WOCKPHARMA) share price today is ₹1460.15
Wockhardt Ltd is listed on NSE
Wockhardt Ltd is listed on BSE
PE Ratio of Wockhardt Ltd is -75.22
PE ratio = Wockhardt Ltd Market price per share / Wockhardt Ltd Earnings per share
Today’s traded volume of Wockhardt Ltd(WOCKPHARMA) is 1.96L.
Today’s market capitalisation of Wockhardt Ltd(WOCKPHARMA) is ₹24211.62Cr.
Wockhardt Ltd(WOCKPHARMA | Price |
---|---|
52 Week High | ₹1536.6 |
52 Week Low | ₹402.65 |
Wockhardt Ltd(WOCKPHARMA) share price is ₹1460.15. It is down -4.98% from its 52 Week High price of ₹1536.6
Wockhardt Ltd(WOCKPHARMA) share price is ₹1460.15. It is up 262.64% from its 52 Week Low price of ₹402.65
Wockhardt Ltd(WOCKPHARMA | Returns |
---|---|
1 Day Returns | -30.05% |
1 Month Returns | 12.25% |
3 Month Returns | 49.51% |
1 Year Returns | 255.32% |